Patents by Inventor Thomas Prince

Thomas Prince has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KRAS(G12V) INHIBITORS
    Publication number: 20260200946
    Abstract: Provided are compounds having the Formula I: and pharmaceutically acceptable salts and compositions, as well as their use in treating conditions responsive to the inhibition of KRAS(G12V).
    Type: Application
    Filed: December 6, 2023
    Publication date: July 16, 2026
    Inventors: Weiwen Ying, Guoqiang Wang, Chenghao Ying, Kevin P. Foley, Zhiyong Wang, Zimo Yang, Thomas Prince, Yaya Wang, Yan Dai, Jinhua Li
  • 4-(3,8-DIAZABICYCLO[3,2,1]OCTAN-3-YL)-PYRIDO[4,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF THE KRAS (G12D) MUTANT ONCOPROTEIN FOR THE TREATMENT OF CANCER
    Publication number: 20260200945
    Abstract: Provided are small molecule inhibitors of the KRAS(G12D) mutant oncoprotein having the structural formula (I) and pharmaceutically acceptable salts and compositions thereof, which are useful for treating cancers and related conditions.
    Type: Application
    Filed: November 30, 2023
    Publication date: July 16, 2026
    Inventors: Weiwen Ying, Chenghao Ying, Kevin P. Foley, Zhiyong Wang, Wei Yin, Liang Ma, Guoqiang Wang, Jinhua Li, Yaya Wang, Yan Dai, Thomas Prince
  • INHIBITORS OF KRAS(G12D)
    Publication number: 20260176290
    Abstract: Provided are small molecule inhibitors of the KRAS (G12D) mutant oncoprotein having the structural formula: and pharmaceutically acceptable salts and compositions thereof, which are useful for treating cancers and related conditions.
    Type: Application
    Filed: February 13, 2026
    Publication date: June 25, 2026
    Inventors: Weiwen Ying, Chenghao Ying, Kevin P. Foley, Zhiyong Wang, Wei Yin, Liang Ma, Guoqiang Wang, Jinhua Li, Yaya Wang, Yan Dai, Thomas Prince
  • METHODS AND COMPOSITIONS FOR MODULATING KRAS(G12D)
    Publication number: 20260070929
    Abstract: Provided are tumor-targeted protein degradation chimeras, termed chaperone-mediated protein degraders (CHAMPs) comprising a first moiety that is capable of binding to a target protein (e.g., KRAS(G12D) or proteins and a second moiety that is capable of binding a chaperone protein or proteins or protein component of chaperone complexes (e.g., HSP90). Pharmaceutical compositions comprising the disclosed CHAMPs and their uses for treating thereof, which are useful for treating cancers and related conditions are also provided.
    Type: Application
    Filed: August 24, 2023
    Publication date: March 12, 2026
    Inventors: Weiwen Ying, Kevin P. Foley, Chenghao Ying, Yaya Wang, Yan Dai, Guoqiang Wang, Wei Yin, Jinhua Li, Thomas Prince, Zhiyong Wang
  • METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION
    Publication number: 20250018047
    Abstract: Provided are PROTACs comprised of a targeting moiety designed to bind KRAS (G12D) linked to a degrader-directing moiety designed to bind an E3 ubiquitin-ligase. Pharmaceutical compositions comprising the disclosed PROTACs and their use in treating cancer and related conditions are also provided.
    Type: Application
    Filed: November 7, 2022
    Publication date: January 16, 2025
    Inventors: Weiwen Ying, Chenghao Ying, Kevin P. Foley, Lingjie Zhang, Mingkai Wang, Long Ye, Thomas Prince, Wei Yin, Yaya Wang
  • INHIBITORS OF KRAS(G12D)
    Publication number: 20240116950
    Abstract: Provided are small molecule inhibitors of the KRAS(G12D) mutant oncoprotein having the structural formula: and pharmaceutically acceptable salts and compositions thereof, which are useful for treating cancers and related conditions.
    Type: Application
    Filed: September 8, 2023
    Publication date: April 11, 2024
    Inventors: Weiwen Ying, Chenghao Ying, Kevin P. Foley, Zhiyong Wang, Wei Yin, Liang Ma, Guoqiang Wang, Jinhua Li, Yaya Wang, Yan Dai, Thomas Prince
  • INHIBITORS OF KRAS(G12D)
    Publication number: 20230365595
    Abstract: Provided are small molecule inhibitors of the KRAS(G12D) mutant oncoprotein having the structural formula: R00F2C—L—R0 and pharmaceutically acceptable salts and compositions thereof, which are useful for treating cancers and related conditions.
    Type: Application
    Filed: May 12, 2023
    Publication date: November 16, 2023
    Applicant: Ranok Therapeutics (Hangzhou) Co. Ltd.
    Inventors: Weiwen Ying, Kevin P. Foley, Chenghao Ying, Zhiyong Wang, Wei Yin, Yaya Wang, Yan Dai, Thomas Prince